Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$832M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$464M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$463M |
| 4 |
LendingTree
TREE
|
+$100M |
| 5 |
MarketAxess Holdings
MKTX
|
+$98.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$429M |
| 2 |
CarMax
KMX
|
+$361M |
| 3 |
Colgate-Palmolive
CL
|
+$347M |
| 4 |
Meta Platforms (Facebook)
META
|
+$266M |
| 5 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$263M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 35.81% |
| 2 | Communication Services | 18.65% |
| 3 | Healthcare | 14.84% |
| 4 | Financials | 8.89% |
| 5 | Technology | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Estee Lauder
EL
$30.4B
| $24.5M | 0.03% |
192,461
| – | – |
|
|
TIF
127
DELISTED
Tiffany & Co.
TIF
| $23.1M | 0.03% |
222,154
+835
| +0.4% | +$79.6K |
|
128
AeroVironment
AVAV
$7.56B
| $21.9M | 0.03% |
389,955
+30,941
| +9% | +$1.57M |
|
|
LN
129
DELISTED
LINE Corporation
LN
| $21.6M | 0.03% |
527,838
+2,797
| +0.5% | +$115K |
|
|
FMI
130
DELISTED
Foundation Medicine, Inc.
FMI
| $20.9M | 0.03% |
307,158
+51,368
| +20% | +$2.66M |
|
131
Apple
AAPL
$4.54T
| $20.8M | 0.03% |
492,204
+20,112
| +4% | +$840K |
|
|
TERP
132
DELISTED
TerraForm Power, Inc
TERP
| $19M | 0.02% |
1,590,928
-802,572
| -34% | -$10M |
|
133
Goldman Sachs
GS
$300B
| $19M | 0.02% |
74,687
| – | – |
|
134
HEICO Corp
HEI
$49.8B
| $18.9M | 0.02% |
391,709
-1,910
| -0.5% | -$89.1K |
|
|
MULE
135
DELISTED
MuleSoft, Inc.
MULE
| $18.3M | 0.02% |
787,555
+183,474
| +30% | +$4.16M |
|
136
Chegg
CHGG
$110M
| $17.7M | 0.02% |
+1,084,701
| New | +$16.6M |
|
|
AGR
137
DELISTED
Avangrid, Inc.
AGR
| $17.7M | 0.02% |
349,000
-133,360
| -28% | -$6.74M |
|
138
Dolby
DLB
$5.51B
| $17.5M | 0.02% |
282,879
-1,265
| -0.4% | -$76.4K |
|
|
BZUN
139
Baozun
BZUN
$167M
| $16.9M | 0.02% |
536,629
+51,589
| +11% | +$1.67M |
|
140
Pacira BioSciences
PCRX
$1.04B
| $16.9M | 0.02% |
370,162
+49,580
| +15% | +$1.96M |
|
141
M&T Bank
MTB
$35.7B
| $16.1M | 0.02% |
93,950
-29,031
| -24% | -$4.82M |
|
142
Eversource Energy
ES
$26.9B
| $16.1M | 0.02% |
254,233
+7,630
| +3% | +$482K |
|
143
BlackRock Floating Rate Income Trust
BGT
$323M
| $16M | 0.02% |
1,150,000
| – | – |
|
144
Exelon
EXC
$47.2B
| $15.9M | 0.02% |
566,611
-5,678
| -1% | -$163K |
|
145
Consolidated Edison
ED
$40.1B
| $15.8M | 0.02% |
185,972
-1,900
| -1% | -$163K |
|
146
Sherwin-Williams
SHW
$82.7B
| $15.8M | 0.02% |
115,335
+1,161
| +1% | +$153K |
|
147
Ameren
AEE
$30.3B
| $15.5M | 0.02% |
262,190
-2,690
| -1% | -$165K |
|
148
Codexis
CDXS
$151M
| $15.4M | 0.02% |
1,842,401
+364,304
| +25% | +$2.52M |
|
149
Veeco
VECO
$3.05B
| $15.2M | 0.02% |
1,023,222
+95,539
| +10% | +$1.65M |
|
|
EXAS
150
DELISTED
Exact Sciences
EXAS
| $15M | 0.02% |
285,951
+26,024
| +10% | +$1.39M |
|
Similar funds
Baillie Gifford & Co's Q4 2017 Portfolio in Review
As of Q4 2017, Baillie Gifford & Co held 210 positions worth $80.4B, up 1.8% from $79B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Baillie Gifford & Co's Q4 2017 filing shows 12 new, 75 increased, 93 reduced and 9 closed positions. Its largest new stake was Thermo Fisher Scientific: 2,423,018 shares worth $460M. The largest sale was Splunk Inc, an estimated $429M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 37% a quarter earlier, followed by Communication Services and Healthcare.
- Baillie Gifford & Co's largest Q4 2017 buy was Thermo Fisher Scientific: 2,423,018 shares worth $460M.
- Baillie Gifford & Co added most to NetEase in Q4 2017, an estimated $832M increase.
- Baillie Gifford & Co's biggest Q4 2017 reduction was Splunk Inc, cutting an estimated $429M.
- Baillie Gifford & Co fully exited Colgate-Palmolive in Q4 2017, selling an estimated $347M.
- Baillie Gifford & Co's ten largest holdings make up 51% of its $80.4B portfolio in Q4 2017.
- Baillie Gifford & Co opened 12 new positions and closed 9 in Q4 2017.
- Baillie Gifford & Co's portfolio value rose 1.8% quarter-over-quarter to $80.4B.
Based on Baillie Gifford & Co's 13F filing for Q4 2017, filed 13 Feb 2018.